Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102


Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.

Lundqvist A, Smith AL, Takahashi Y, Wong S, Bahceci E, Cook L, Ramos C, Tawab A, McCoy JP Jr, Read EJ, Khuu HM, Bolan CD, Joo J, Geller N, Leitman SF, Calandra G, Dunbar C, Kurlander R, Childs RW.

J Immunol. 2013 Dec 15;191(12):6241-9. doi: 10.4049/jimmunol.1301148. Epub 2013 Nov 15.


The economic burden of opioid-related poisoning in the United States.

Inocencio TJ, Carroll NV, Read EJ, Holdford DA.

Pain Med. 2013 Oct;14(10):1534-47. doi: 10.1111/pme.12183. Epub 2013 Jul 10.


Therapeutic potential of mesenchymal stem cells for severe acute lung injury.

Matthay MA, Thompson BT, Read EJ, McKenna DH Jr, Liu KD, Calfee CS, Lee JW.

Chest. 2010 Oct;138(4):965-72. doi: 10.1378/chest.10-0518. Review.


Voluntarily reported unintentional injections from epinephrine auto-injectors.

Simons FE, Edwards ES, Read EJ Jr, Clark S, Liebelt EL.

J Allergy Clin Immunol. 2010 Feb;125(2):419-423.e4. doi: 10.1016/j.jaci.2009.10.056.


Hazards of unintentional injection of epinephrine from autoinjectors: a systematic review.

Simons FE, Lieberman PL, Read EJ Jr, Edwards ES.

Ann Allergy Asthma Immunol. 2009 Apr;102(4):282-7. doi: 10.1016/S1081-1206(10)60332-8. Review.


Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes.

Tawab A, Fan Y, Read EJ, Kurlander RJ.

Transfusion. 2009 Mar;49(3):536-47. doi: 10.1111/j.1537-2995.2008.02020.x.


A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas.

Mackall CL, Rhee EH, Read EJ, Khuu HM, Leitman SF, Bernstein D, Tesso M, Long LM, Grindler D, Merino M, Kopp W, Tsokos M, Berzofsky JA, Helman LJ.

Clin Cancer Res. 2008 Aug 1;14(15):4850-8. doi: 10.1158/1078-0432.CCR-07-4065.


A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products.

Gee AP, Sumstad D, Stanson J, Watson P, Proctor J, Kadidlo D, Koch E, Sprague J, Wood D, Styers D, McKenna D, Gallelli J, Griffin D, Read EJ, Parish B, Lindblad R.

Cytotherapy. 2008;10(4):427-35. doi: 10.1080/14653240802075476.


Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings.

Arbab AS, Janic B, Knight RA, Anderson SA, Pawelczyk E, Rad AM, Read EJ, Pandit SD, Frank JA.

FASEB J. 2008 Sep;22(9):3234-46. doi: 10.1096/fj.07-105676. Epub 2008 Jun 12.


Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction.

de Silva R, Raval AN, Hadi M, Gildea KM, Bonifacino AC, Yu ZX, Yau YY, Leitman SF, Bacharach SL, Donahue RE, Read EJ, Lederman RJ.

Eur Heart J. 2008 Jul;29(14):1772-82. doi: 10.1093/eurheartj/ehn216. Epub 2008 May 23.


Evaluation of gene expression profiles of immature dendritic cells prepared from peripheral blood mononuclear cells.

Shin JW, Jin P, Fan Y, Slezak S, David-Ocampo V, Khuu HM, Read EJ, Wang E, Marincola FM, Stroncek DF.

Transfusion. 2008 Apr;48(4):647-57. doi: 10.1111/j.1537-2995.2007.01615.x. Epub 2008 Feb 12.


Multicenter study on in vitro characterization of dendritic cells.

Eichler H, Nguyen XD, Roelen D, Celluzzi CM, McKenna D, Pamphilon D, Blair A, Read EJ, Takahashi TA, Szczepiorkowski ZM; Biomedical Excellence for Safer Transfusion Collaborative.

Cytotherapy. 2008;10(1):21-9. doi: 10.1080/14653240701744263.


A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.

Mielke S, Nunes R, Rezvani K, Fellowes VS, Venne A, Solomon SR, Fan Y, Gostick E, Price DA, Scotto C, Read EJ, Barrett AJ.

Blood. 2008 Apr 15;111(8):4392-402. Epub 2007 Sep 18.


Mobilization, collection, and immunomagnetic selection of peripheral blood CD34 cells in recovered aplastic anemia patients.

Sloand EM, Read EJ, Scheinberg P, Tang Y, More K, Leitman SF, Maciejewski J, Young NS.

Transfusion. 2007 Jul;47(7):1250-3.


Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.

Mielke S, Rezvani K, Savani BN, Nunes R, Yong AS, Schindler J, Kurlander R, Ghetie V, Read EJ, Solomon SR, Vitetta ES, Barrett AJ.

Blood. 2007 Sep 1;110(5):1689-97. Epub 2007 May 3.


Blood collection and transfusion in the United States in 2001.

Sullivan MT, Cotten R, Read EJ, Wallace EL.

Transfusion. 2007 Mar;47(3):385-94.


Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method.

Khuu HM, Patel N, Carter CS, Murray PR, Read EJ.

Transfusion. 2006 Dec;46(12):2071-82.


T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.

Montero A, Savani BN, Shenoy A, Read EJ, Carter CS, Leitman SF, Mielke S, Rezvani K, Childs R, Barrett AJ.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1318-25.


Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.

Fowler DH, Odom J, Steinberg SM, Chow CK, Foley J, Kogan Y, Hou J, Gea-Banacloche J, Sportes C, Pavletic S, Leitman S, Read EJ, Carter C, Kolstad A, Fox R, Beatty GL, Vonderheide RH, Levine BL, June CH, Gress RE, Bishop MR.

Biol Blood Marrow Transplant. 2006 Nov;12(11):1150-60.


A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.

Kurlander RJ, Tawab A, Fan Y, Carter CS, Read EJ.

Transfusion. 2006 Sep;46(9):1494-504.


Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood.

Moroff G, Eichler H, Brand A, Kekomäki R, Kurtz J, Letowska M, Pamphilon D, Read EJ, Porretti L, Lecchi L, Reems JA, Sacher R, Seetharaman S, Takahashi TA; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2006 Apr;46(4):507-15.


Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.

Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G, Read EJ, Khuu HM, Leitman SF, Horne M, Csako G, Dunbar CE, Waclawiw MA, Cannon RO 3rd.

J Am Coll Cardiol. 2005 Nov 1;46(9):1643-8.


Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.

Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA.

NMR Biomed. 2005 Dec;18(8):553-9.


Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.

Zhang H, Chua KS, Guimond M, Kapoor V, Brown MV, Fleisher TA, Long LM, Bernstein D, Hill BJ, Douek DC, Berzofsky JA, Carter CS, Read EJ, Helman LJ, Mackall CL.

Nat Med. 2005 Nov;11(11):1238-43. Epub 2005 Oct 16.


Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis.

Arbab AS, Pandit SD, Anderson SA, Yocum GT, Bur M, Frenkel V, Khuu HM, Read EJ, Frank JA.

Stem Cells. 2006 Mar;24(3):671-8. Epub 2005 Sep 22. Erratum in: Stem Cells. 2006 Apr;24(4):1142.


Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.

Morgan RA, Walker R, Carter CS, Natarajan V, Tavel JA, Bechtel C, Herpin B, Muul L, Zheng Z, Jagannatha S, Bunnell BA, Fellowes V, Metcalf JA, Stevens R, Baseler M, Leitman SF, Read EJ, Blaese RM, Lane HC.

Hum Gene Ther. 2005 Sep;16(9):1065-74.


Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

Savani BN, Rezvani K, Mielke S, Montero A, Kurlander R, Carter CS, Leitman S, Read EJ, Childs R, Barrett AJ.

Blood. 2006 Feb 15;107(4):1688-95. Epub 2005 Aug 30.


Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning.

Montero A, Savani BN, Kurlander R, Read EJ, Leitman SF, Childs R, Solomon SR, Barrett AJ.

Br J Haematol. 2005 Sep;130(5):733-9.


Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome.

Solomon SR, Savani BN, Childs R, Montero A, Boss C, Read EJ, Leitman SF, Barrett AJ.

Biol Blood Marrow Transplant. 2005 Aug;11(8):619-26.


Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.

Carbone DP, Ciernik IF, Kelley MJ, Smith MC, Nadaf S, Kavanaugh D, Maher VE, Stipanov M, Contois D, Johnson BE, Pendleton CD, Seifert B, Carter C, Read EJ, Greenblatt J, Top LE, Kelsey MI, Minna JD, Berzofsky JA.

J Clin Oncol. 2005 Aug 1;23(22):5099-107. Epub 2005 Jun 27.


Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

Solomon SR, Mielke S, Savani BN, Montero A, Wisch L, Childs R, Hensel N, Schindler J, Ghetie V, Leitman SF, Mai T, Carter CS, Kurlander R, Read EJ, Vitetta ES, Barrett AJ.

Blood. 2005 Aug 1;106(3):1123-9. Epub 2005 Apr 7.


Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.

Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, McCoy JP, Read EJ, Khuu HM, Leitman SF, Finkel T, Cannon RO 3rd.

Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):296-301. Epub 2004 Nov 29.


Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation.

Bishop MR, Steinberg SM, Gress RE, Hardy NM, Marchigiani D, Kasten-Sportes C, Dean R, Pavletic SZ, Gea-Banacloche J, Castro K, Hakim F, Krumlauf M, Read EJ, Carter C, Leitman SF, Fowler DH.

Br J Haematol. 2004 Sep;126(6):837-43.


Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.

Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S, Gress R.

J Clin Oncol. 2004 Oct 1;22(19):3886-92. Epub 2004 Aug 16.


Cell processing: current status and future directions.

Stroncek D, Read EJ.

Yonsei Med J. 2004 Jun 30;45 Suppl:1-4.


Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.

Khuu HM, Stock F, McGann M, Carter CS, Atkins JW, Murray PR, Read EJ.

Cytotherapy. 2004;6(3):183-95.


Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.

Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA.

Blood. 2004 Aug 15;104(4):1217-23. Epub 2004 Apr 20.


Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

Hirshberg B, Rother KI, Digon BJ 3rd, Lee J, Gaglia JL, Hines K, Read EJ, Chang R, Wood BJ, Harlan DM.

Diabetes Care. 2003 Dec;26(12):3288-95.


Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.

Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, Read EJ, Lansdorp PM, Young NS.

Lancet. 2003 Nov 15;362(9396):1628-30.


Management of severe VWD with cryoprecipitate collected by repeated apheresis of a single dedicated donor.

Pomper GJ, Rick ME, Epstein JS, Read EJ, Leitman SF.

Transfusion. 2003 Nov;43(11):1514-21.


Going where the action is: cellular therapy for diabetes mellitus.

Read EJ.

Cytotherapy. 2003;5(3):241-2. No abstract available.


Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation.

Solomon SR, Nakamura R, Read EJ, Leitman SF, Carter C, Childs R, Dunbar CE, Young NS, Barrett AJ.

Bone Marrow Transplant. 2003 May;31(9):783-8.


Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences.

Khuu HM, Cowley H, David-Ocampo V, Carter CS, Kasten-Sportes C, Wayne AS, Solomon SR, Bishop MR, Childs RM, Read EJ.

Cytotherapy. 2002;4(6):539-49.


Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation.

Solomon SR, Tran T, Carter CS, Donnelly S, Hensel N, Schindler J, Bahceci E, Ghetie V, Michálek J, Mavroudis D, Read EJ, Vitetta ES, Barrett AJ.

Cytotherapy. 2002;4(5):395-406.


High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia.

Huhn RD, Fogarty PF, Nakamura R, Read EJ, Leitman SF, Rick ME, Kimball J, Greene A, Hansmann K, Gratwohl A, Young N, Barrett AJ, Dunbar CE.

Blood. 2003 Jan 1;101(1):71-7. Epub 2002 Aug 8.


Selection and expansion of T cell from untreated patients with CLL: source of cells for immune reconstitution?

Husebekk A, Fellowes V, Read EJ, Williams J, Petrus MJ, Gress RE, Fowler DH.

Cytotherapy. 2000;2(3):187-93.


Supplemental Content

Support Center